NanoViricides Inc Share Price Today: Live Updates & Key Insights

NanoViricides Inc share price today is $1.03, up -1.9%. The stock opened at $1.03 against the previous close of $1.05, with an intraday high of $1.05 and low of $1.005.

NanoViricides Inc Share Price Chart

NanoViricides Inc

us-stock
To Invest in {{usstockname}}
us-stock

NanoViricides Inc Share Price Performance

$1.03 -0.019(-1.9%) NNVC at 23 Mar 2026 02:29 PM Biotechnology
Lowest Today 1.005
Highest Today 1.05
Today’s Open 1.03
Prev. Close 1.05
52 Week High 2.23
52 Week Low 0.85
Day’s Range: Low 1.005 High 1.05
52-Week Range: Low 0.85 High 2.23
1 day return -
1 Week return -8.77
1 month return +5.05
3 month return -16.8
6 month return -28.02
1 year return -21.8
3 year return -18.11
5 year return -79.24
10 year return -

NanoViricides Inc Institutional Holdings

NanoViricides Inc Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

NanoViricides Inc Fundamentals

Market Cap 22.24 M

PB Ratio 2.048

PE Ratio 0.0

Enterprise Value 17.52 M

Total Assets 8.82 M

Volume 224638

NanoViricides Inc Company Financials

Annual Revenue FY25:0 0.0M, FY24:0 0.0M, FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M

Annual Profit FY25:-743805 -0.7M, FY24:-759014 -0.8M, FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M

Annual Net worth FY25:-9466966 -9.5M, FY24:-8294146 -8.3M, FY23:-8588573 -8.6M, FY22:-8100127 -8.1M, FY21:-8907594 -8.9M

Quarterly Revenue Q4/2025:null 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q4/2024:0 0.0M

Quarterly Profit Q4/2025:-133084 -0.1M, Q3/2025:-132820 -0.1M, Q2/2025:-161126 -0.2M, Q1/2025:-191182 -0.2M, Q4/2024:null 0.0M

Quarterly Net worth Q4/2025:-2220719 -2.2M, Q3/2025:-1785058 -1.8M, Q2/2025:-2095880 -2.1M, Q1/2025:-2216783 -2.2M, Q4/2024:-2027491 -2.0M

About NanoViricides Inc & investment objective

Company Information NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs to combat viral infections. The company's product portfolio includes NV-387 drug candidate developed for RSV and influenza indications and has completed phase 1a/1b human clinical trial for the evaluation of safety and tolerability; NV-387 as an active ingredient of drug product formulations for the treatment of COVID infections comprising NV-CoV-2 Oral Syrup and NV-CoV-2 Oral Gummies developed for the treatment of COVID infection, a semi-solid fixed-dose form, which are in phase 1a/1b human clinical trials for enabling body-weight-based dose titration as is required for pediatric treatments. It also offers NV-387 Solution for injection, infusion, and inhalation to treat severe cases that are not hospitalized and carried out by an injection; and injectable solution that delivered directly into the lungs as a fog created using portable battery operated nebulizer devices, which enables action at infection by a respiratory virus, such as coronaviruses, RSV, influenzas, human meta-pneumovirus, certain adenoviruses, and other infections, that can lead to severe pneumonia. In addition, the company develops NV-HHV-1, a skin cream for the treatment of Shingles rash, which has completed non-clinical pharmacology studies; oral drug with NV-HHV-1 as the active ingredient for the treatment of HSV-1 cold sores and HSV-2 genital ulcers; and other drug candidates in HIVCide program for the treatment of Dengue and Ebola virus, as well as provides Nanoviricide platform technology to treat various types of viruses. NanoViricides, Inc. was incorporated in 2005 and is headquartered in Shelton, Connecticut.

Organisation Biotechnology

Employees 7

Industry Biotechnology

CEO Dr. Anil R. Diwan Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

NanoViricides Inc FAQs

What is the share price of NanoViricides Inc today?

The current share price of NanoViricides Inc is $1.03.

Can I buy NanoViricides Inc shares in India?

Yes, Indian investors can buy NanoViricides Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy NanoViricides Inc shares in India?

You can easily invest in NanoViricides Inc shares from India by:

Can I buy fractional shares of NanoViricides Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of NanoViricides Inc?

NanoViricides Inc has a market cap of $22.24 M.

In which sector does NanoViricides Inc belong?

NanoViricides Inc operates in the Biotechnology sector.

What documents are required to invest in NanoViricides Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of NanoViricides Inc?

The PE ratio of NanoViricides Inc is N/A and the PB ratio is 2.05.